Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

Sugen files IND for angiogenesis inhibitor

July 3, 1997

ACT licenses rights to patents related to dendritic cell therapy

July 3, 1997

Kyowa Hakko discovers antitumor compounds in Streptomyces culture

July 3, 1997

PN-401: a new uridine prodrug from Pro-Neuron

July 1, 1997

Lisofylline not associated with reduction in high-dose IL-2 toxicity

June 30, 1997

Advisory committee recommends Taxol for KS

June 27, 1997

PEG-rHuMGDF enhances platelet recovery in cancer patients undergoing chemotherapy

June 27, 1997

Cytel and Baxter enter research agreement for the development of ex vivo cancer therapy

June 27, 1997

MDR-reversing agent from Mitsui Toatsu characterized in vitro and in vivo

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...